Prasterone Patent Expiration
Prasterone is Used for managing dyspareunia in menopausal women with vulvar and vaginal atrophy. It was first introduced by Millicent Pharma Ltd
Prasterone Patents
Given below is the list of patents protecting Prasterone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Intrarosa | US8268806 | Pharmaceutical compositions | Mar 19, 2031 | Millicent |
| Intrarosa | US8957054 | Pharmaceutical compositions | Jan 08, 2030 | Millicent |
| Intrarosa | US8629129 | Pharmaceutical compositions | Aug 07, 2028 | Millicent |
Prasterone's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List